These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35508216)

  • 1. Examining the effect of chronic intranasal oxytocin administration on the neuroanatomy and behavior of three autism-related mouse models.
    Lindenmaier Z; Ellegood J; Stuive M; Easson K; Yee Y; Fernandes D; Foster J; Anagnostou E; Lerch JP
    Neuroimage; 2022 Aug; 257():119243. PubMed ID: 35508216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autism.
    Derieux C; Léauté A; Brugoux A; Jaccaz D; Terrier C; Pin JP; Kniazeff J; Le Merrer J; Becker JAJ
    Neuropsychopharmacology; 2022 Aug; 47(9):1680-1692. PubMed ID: 35418620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
    Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
    Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZ
    Kitagawa K; Matsumura K; Baba M; Kondo M; Takemoto T; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Mol Brain; 2021 Mar; 14(1):56. PubMed ID: 33726803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term exposure to intranasal oxytocin in a mouse autism model.
    Bales KL; Solomon M; Jacob S; Crawley JN; Silverman JL; Larke RH; Sahagun E; Puhger KR; Pride MC; Mendoza SP
    Transl Psychiatry; 2014 Nov; 4(11):e480. PubMed ID: 25386957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
    Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
    Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-carotene as a novel therapy for the treatment of "Autistic like behavior" in animal models of Autism.
    Avraham Y; Berry EM; Donskoy M; Ahmad WA; Vorobiev L; Albeck A; Mankuta D
    Behav Brain Res; 2019 May; 364():469-479. PubMed ID: 28963040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
    Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
    Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial.
    Le J; Zhang L; Zhao W; Zhu S; Lan C; Kou J; Zhang Q; Zhang Y; Li Q; Chen Z; Fu M; Montag C; Zhang R; Yang W; Becker B; Kendrick KM
    Psychother Psychosom; 2022; 91(5):335-347. PubMed ID: 35545057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
    Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
    J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism.
    Chao OY; Pathak SS; Zhang H; Dunaway N; Li JS; Mattern C; Nikolaus S; Huston JP; Yang YM
    Mol Brain; 2020 Aug; 13(1):111. PubMed ID: 32778145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism.
    Peñagarikano O; Lázaro MT; Lu XH; Gordon A; Dong H; Lam HA; Peles E; Maidment NT; Murphy NP; Yang XW; Golshani P; Geschwind DH
    Sci Transl Med; 2015 Jan; 7(271):271ra8. PubMed ID: 25609168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
    Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
    Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
    Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
    Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.
    Dadds MR; MacDonald E; Cauchi A; Williams K; Levy F; Brennan J
    J Autism Dev Disord; 2014 Mar; 44(3):521-31. PubMed ID: 23888359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.
    Mines MA; Yuskaitis CJ; King MK; Beurel E; Jope RS
    PLoS One; 2010 Mar; 5(3):e9706. PubMed ID: 20300527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
    Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
    Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial.
    Aoki Y; Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Takao H; Kawakubo Y; Kasai K; Yamasue H
    Mol Psychiatry; 2015 Apr; 20(4):447-53. PubMed ID: 25070538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
    Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
    Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
    Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.